Occupational asbestos exposure and the incidence of non-hodgkin lymphoma of the gastrointestinal tract: An ecologic study

Annals of Epidemiology

Volumn 14, Issue 3, 2004, Pages 168-171

  Treggiari, Miriam M ^a   Weiss, Noel S ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Environmental Exposure; Immunoproliferative Disorders; Lymphoma; Lymphoproliferative Disorders; Non Hodgkin

Indexed keywords

ASBESTOS;

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER INCIDENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; ECOLOGY; GASTROINTESTINAL DISEASE; GEOGRAPHY; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MESOTHELIOMA; NONHODGKIN LYMPHOMA; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; UNITED STATES;

EID: 1342345290     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(03)00241-2     Document Type: Article

References (14)

1. Becker N., Berger J., Bolm-Audorff U. Asbestos exposure and malignant lymphomas-a review of the epidemiological literature. Int Arch Occup Environ Health. 74:2001;459-469.
2. Ross R., Dworsky R., Nichols P., Paganini-Hill A., Wright W., Koss M., et al. Asbestos exposure and lymphomas of the gastrointestinal tract and oral cavity. Lancet. 2:1982;1118-1120.
3. Bengtsson N.O., Hardell L., Eriksson M. Asbestos exposure and malignant lymphoma. Lancet. 2:1982;1463.
4. Spirtas R., Heineman E.F., Bernstein L., Beebe G.W., Keehn R.J., Stark A., et al. Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med. 51:1994;804-811.
5. McDonald A.D., McDonald J.C. Malignant mesothelioma in North America. Cancer. 46:1980;1650-1656.
6. Mark E.J., Yokoi T. Absence of evidence for a significant background incidence of diffuse malignant mesothelioma apart from asbestos exposure. Ann N Y Acad Sci. 643:1991;196-204.
7. Ries L.A.G., Kosary C.L., Hankey B.F. SEER Cancer Statistics Review, 1973-1994. 1997;National Cancer Institute, Bethesda, MD. (NIH Publication No. 97-2789).
8. Zippin C., Lum D., Hankey B.F. Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer. 76:1995;2343-2350.
9. Nattinger A.B., McAuliffe T.L., Schapira M.M. Generalizability of the surveillance, epidemiology, and end results registry population: factors relevant to epidemiologic and health care research. J Clin Epidemiol. 50:1997;939-945.
10. Summary Staging Manual, 2000. Available at: http://seer.cancer.gov/ Publications/SummaryStage/SEER . Accessed, June 18, 2001.
11. Guindi M. Role of Helicobacter pylori in the pathogenesis of gastric carcinoma and progression of lymphoid nodules to lymphoma. Can J Gastroenterol. 13:1999;224-227.
12. Crump M., Gospodarowicz M., Shepherd F.A. Lymphoma of the gastrointestinal tract. Semin Oncol. 26:1999;324-337.
13. Catassi C., Fabiani E., Corrao G., Barbato M., De Renzo A., Carella A.M., et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA. 287:2002;1413-1419.
14. Mariette X. Lymphomas in patients with Sjogren's syndrome: review of the literature and physiopathologic hypothesis. Leuk Lymphoma. 33:1999;93-99.